Literature DB >> 18396381

Development of hyperactivity after hearing loss in a computational model of the dorsal cochlear nucleus depends on neuron response type.

Roland Schaette1, Richard Kempter.   

Abstract

Cochlear damage can change the spontaneous firing rates of neurons in the dorsal cochlear nucleus (DCN). Increased spontaneous firing rates (hyperactivity) after acoustic trauma have been observed in the DCN of rodents such as hamsters, chinchillas and rats. This hyperactivity has been interpreted as a neural correlate of tinnitus. In cats, however, the spontaneous firing rates of DCN neurons were not significantly elevated after acoustic trauma. Species-specific spontaneous firing rates after cochlear damage might be attributable to differences in the response types of DCN neurons: In gerbils, type III response characteristics are predominant, whereas in cats type IV responses are more frequent. To address the question of how the development of hyperactivity after cochlear damage depends on the response type of DCN neurons, we use a computational model of the basic circuit of the DCN. By changing the strength of two types of inhibition, we can reproduce salient features of the responses of DCN neurons. Simulated cochlear damage, which decreases the activity of auditory nerve fibers, is assumed to activate homeostatic plasticity in projection neurons (PNs) of the DCN. We find that the resulting spontaneous firing rates depend on the response type of DCN PNs: PNs with type III and type IV-T response characteristics may become hyperactive, whereas type IV PNs do not develop increased spontaneous firing rates after acoustic trauma. This theoretical framework for the mechanisms and circumstances of the development of hyperactivity in central auditory neurons might also provide new insights into the development of tinnitus.

Entities:  

Mesh:

Year:  2008        PMID: 18396381     DOI: 10.1016/j.heares.2008.02.006

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  15 in total

1.  Which affective temperaments are most expressed in patients with chronic sub-jective tinnitus?

Authors:  M Trifunovic; Lj Zivic; D Ignjatovic-Ristic; J Sretenovic; N Rancic; I Ristic
Journal:  Hippokratia       Date:  2020 Apr-Jun       Impact factor: 0.471

Review 2.  Chemical exposure and hearing loss.

Authors:  Pierre Campo; Thais C Morata; OiSaeng Hong
Journal:  Dis Mon       Date:  2013-04       Impact factor: 3.800

3.  Degeneration in the ventral cochlear nucleus after severe noise damage in mice.

Authors:  J Feng; J Bendiske; D K Morest
Journal:  J Neurosci Res       Date:  2011-11-23       Impact factor: 4.164

Review 4.  Tinnitus: Models and mechanisms.

Authors:  James A Kaltenbach
Journal:  Hear Res       Date:  2010-12-10       Impact factor: 3.208

5.  Comparison and contrast of noise-induced hyperactivity in the dorsal cochlear nucleus and inferior colliculus.

Authors:  N F Manzoor; Y Gao; F Licari; J A Kaltenbach
Journal:  Hear Res       Date:  2012-04-13       Impact factor: 3.208

6.  Reversible induction of phantom auditory sensations through simulated unilateral hearing loss.

Authors:  Roland Schaette; Charlotte Turtle; Kevin J Munro
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

Review 7.  Maladaptive neural synchrony in tinnitus: origin and restoration.

Authors:  Jos J Eggermont; Peter A Tass
Journal:  Front Neurol       Date:  2015-02-17       Impact factor: 4.003

8.  Abnormal Auditory Gain in Hyperacusis: Investigation with a Computational Model.

Authors:  Peter U Diehl; Roland Schaette
Journal:  Front Neurol       Date:  2015-07-15       Impact factor: 4.003

9.  Computational models of neurophysiological correlates of tinnitus.

Authors:  Roland Schaette; Richard Kempter
Journal:  Front Syst Neurosci       Date:  2012-05-08

10.  Auditory evoked magnetic fields in individuals with tinnitus.

Authors:  Magdalena Sereda; Peyman Adjamian; Mark Edmondson-Jones; Alan R Palmer; Deborah A Hall
Journal:  Hear Res       Date:  2013-04-29       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.